The Federal Circuit revived UC Berkeley’s claim to key CRISPR gene editing patents, directing the USPTO to reconsider if its findings predate Broad Institute’s.
FDA declined to appeal a court ruling invalidating its 2024 LDT rule, concluding its push to expand regulatory control over lab-developed tests.
In Sigray v. Zeiss, the Federal Circuit reversed a PTAB ruling, holding that an implicit claim construction error led to wrongly upholding X-ray imaging patent claims.
A Ninth Circuit panel heard arguments on whether to revive a proposed class action alleging misleading expiration labels on Monsanto’s Roundup products, with some skepticism toward claims against a...
